519 related articles for article (PubMed ID: 16214395)
1. Pathology of nonalcoholic steatohepatitis.
Brunt EM
Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395
[TBL] [Abstract][Full Text] [Related]
2. Role of liver biopsy in nonalcoholic fatty liver disease.
Nalbantoglu IL; Brunt EM
World J Gastroenterol; 2014 Jul; 20(27):9026-37. PubMed ID: 25083076
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis: definition and pathology.
Brunt EM
Semin Liver Dis; 2001; 21(1):3-16. PubMed ID: 11296695
[TBL] [Abstract][Full Text] [Related]
4. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
6. Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).
Giashuddin S; Alawad M
Methods Mol Biol; 2022; 2455():1-18. PubMed ID: 35212981
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.
Pearce SG; Thosani NC; Pan JJ
Biomark Res; 2013 Feb; 1(1):7. PubMed ID: 24252302
[TBL] [Abstract][Full Text] [Related]
8. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease.
Lai J; Wang HL; Zhang X; Wang H; Liu X
Arch Pathol Lab Med; 2022 Aug; 146(8):940-946. PubMed ID: 34871361
[TBL] [Abstract][Full Text] [Related]
9. Non-Alcoholic Fatty Liver Disease, an Overview.
Nd AM
Integr Med (Encinitas); 2019 Apr; 18(2):42-49. PubMed ID: 31341444
[TBL] [Abstract][Full Text] [Related]
10. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
[TBL] [Abstract][Full Text] [Related]
11. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan.
Sumida Y; Eguchi Y; Ono M
World J Hepatol; 2010 Oct; 2(10):374-83. PubMed ID: 21160946
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and diagnosis of NAFLD/NASH.
Hashimoto E; Taniai M; Tokushige K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
14. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease.
Dai YN; Xu CF; Pan HY; Huang HJ; Chen MJ; Li YM; Yu CH
World J Clin Cases; 2022 May; 10(13):4097-4109. PubMed ID: 35665109
[TBL] [Abstract][Full Text] [Related]
15. Current histological classification of NAFLD: strength and limitations.
Bedossa P
Hepatol Int; 2013 Dec; 7 Suppl 2():765-70. PubMed ID: 26202292
[TBL] [Abstract][Full Text] [Related]
16. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
[TBL] [Abstract][Full Text] [Related]
17. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
[TBL] [Abstract][Full Text] [Related]
18. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ;
Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
[TBL] [Abstract][Full Text] [Related]
19. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA;
Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.
Basaranoglu M; Neuschwander-Tetri BA
Gastroenterol Hepatol (N Y); 2006 Apr; 2(4):282-291. PubMed ID: 28286458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
